Sign inJoin waitlistJoin the waitlist

Diane Reidy-Lagunes

Division Chief · Duke University Hospital

Credentials: · · · ·

History

Duke University Hospital
Present
Duke University Hospital
Present

Icahn School of Medicine at Mount Sinai
2004–2006
Internal Medicine
2001–2004
SUNY Downstate University Health Sciences University College of Medicine
1997–2001

Research

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 538 citations
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Journal of Clinical Oncology · 2019 · 523 citations
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JAMA Oncology · 2018 · 511 citations

LS
Leonard Saltz
41 papers
NR
Nitya Raj
39 papers · 6 as a fellow
AC
Andrea Cercek
23 papers
JS
Jinru Shia
20 papers
ZS
Zsofia Stadler
20 papers
NS
Neil Segal
19 papers
LT
Laura Tang
18 papers
MW
Martin Weiser
17 papers
Lisa Bodei
16 papers
Peter Allen
16 papers · 2 as a resident
RY
Rona Yaeger
16 papers
EO
Eileen O'Reilly
15 papers

Clinical trials

A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2017–2024
Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2010–2014
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2008–2020
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2029